The decreased spexin levels were observed in type 2 DM, and further more decreased in type 2 DM with CVD patients compared to controls indicatingthat spexin levels could be served as an early prediction of obesity-induced T2DM with CVD risk. Here, SPX is linked to obesity due to melanocortin 4 receptor deficiency.